XPS and HR TEM Elucidation of the Diversity of Titania-Supported Single-Site Ir Catalyst Performance in Spin-Selective Propene Hydrogenation.

Immobilized [Ir(COD)Cl]2-Linker/TiO2 catalysts with linkers containing Py, P(Ph)2 and N(CH3)2 functional groups were prepared. The catalysts were tested via propene hydrogenation with parahydrogen in a temperature range from 40 °C to 120 °C which was monitored via NMR. The catalytic behavior of [Ir(COD)Cl]2-Linker/TiO2 is explained on the basis of quantitative and qualitative XPS data analysis performed for the catalysts before and after the reaction at 120 °C. It is shown that the temperature dependence of propene conversion and the enhancement of the NMR signal are explained via a combination of the stabilities of both the linker and immobilized [Ir(COD)Cl]2 complex. It is demonstrated that the N(CH3)2-linker is the most stable at the surface of TiO2 under used reaction conditions. As a result, only this sample shows a rise in the enhancement of the NMR signal in the 100-120 °C temperature range.

Electrospun Scaffolds Enriched with Nanoparticle-Associated DNA: General Properties, DNA Release and Cell Transfection.

Biomaterial-mediated, spatially localized gene delivery is important for the development of cell-populated scaffolds used in tissue engineering. Cells adhering to or penetrating into such a scaffold are to be transfected with a preloaded gene that induces the production of secreted proteins or cell reprogramming. In the present study, we produced silica nanoparticles-associated pDNA and electrospun scaffolds loaded with such nanoparticles, and studied the release of pDNA from scaffolds and cell-to-scaffold interactions in terms of cell viability and pDNA transfection efficacy. The pDNA-coated nanoparticles were characterized with dynamic light scattering and transmission electron microscopy. Particle sizes ranging from 56 to 78 nm were indicative of their potential for cell transfection. The scaffolds were characterized using scanning electron microscopy, X-ray photoelectron spectroscopy, stress-loading tests and interaction with HEK293T cells. It was found that the properties of materials and the pDNA released vary, depending on the scaffold's composition. The scaffolds loaded with pDNA-nanoparticles do not have a pronounced cytotoxic effect, and can be recommended for cell transfection. It was found that (pDNA-NPs) + PEI9-loaded scaffold demonstrates good potential for cell transfection. Thus, electrospun scaffolds suitable for the transfection of inhabiting cells are eligible for use in tissue engineering.

Activated Carbon-Enriched Electrospun-Produced Scaffolds for Drug Delivery/Release in Biological Systems.

To vectorize drug delivery from electrospun-produced scaffolds, we introduce a thin outer drug retention layer produced by electrospinning from activated carbon nanoparticles (ACNs)-enriched polycaprolacton (PCL) suspension. Homogeneous or coaxial fibers filled with ACNs were produced by electrospinning from different PCL-based suspensions. Stable ACN suspensions were selected by sorting through solvents, stabilizers and auxiliary components. The ACN-enriched scaffolds produced were characterized for fiber diameter, porosity, pore size and mechanical properties. The scaffold structure was analyzed by scanning electron microscopy and X-ray photoelectron spectroscopy. It was found that ACNs were mainly coated with a polymer layer for both homogeneous and coaxial fibers. Drug binding and release from the scaffolds were tested using tritium-labeled sirolimus. We showed that the kinetics of sirolimus binding/release by ACN-enriched scaffolds was determined by the fiber composition and differed from that obtained with a free ACN. ACN-enriched scaffolds with coaxial and homogeneous fibers had a biocompatibility close to scaffold-free AC, as was shown by the cultivation of human gingival fibroblasts and umbilical vein cells on scaffolds. The data obtained demonstrated that ACN-enriched scaffolds had good physico-chemical properties and biocompatibility and, thus, could be used as a retaining layer for vectored drug delivery.

Activated Carbon for Drug Delivery from Composite Biomaterials: The Effect of Grinding on Sirolimus Binding and Release.

Activated carbon (AC) could be potentially useful as a drug carrier in fiber polymer scaffolds destined for prolonged drug delivery. To be introduced, AC must be ground into smaller-sized particles to be introduced in scaffolds, as most biocompatible scaffolds consist of fibers with a diameter of less than 1 µm. In this study, the adsorption of sirolimus (SRL) from phosphate-buffered saline (PBS) solution and blood plasma (BP) onto AC of AX-21 type, as well as the release of SRL from AC depending on its fragmentation, were studied. Two-stage grinding of the AC, first with a ball mill, and then with a bead mill, was performed. Grinding with a bead mill was performed either in water or in polyvinylpyrrolidone to prevent aggregation of AC particles. Dynamic light scattering and scanning electron microscopy (SEM) demonstrated that the size of the particles obtained after grinding with a ball mill was 100-10,000 nm, and after grinding with a bead mill, 100-300 nm. Adsorption in PBS was significantly higher than in BP for all fractions, and depended on SRL concentration. The fraction obtained after grinding with a ball mill showed maximal SRL adsorption, both in PBS and BP, and slow SRL release, in comparison with other fractions. The 100-300 nm AC fractions were able to adsorb and completely release SRL into BP, in contrast to other fractions, which strongly bound a significant amount of SRL. The data obtained are to be used for controlled SRL delivery, and thus in the modification of drug delivery in biological media.

Dataset N-doping of alumina thin film support of catalysts.

The search for the ways of thermal stabilization of supported metal catalysts is an important challenge in the modern catalysis. Chemical modification of support seems to be the most versatile approach to stabilize the metal particles against sintering and alter their catalytic performance. Also for such modification nitrogen doping can be used and is considered rather perspective. In a recent manuscript (A.M. Dmitrachkov, R.I. Kvon, A.V. Nartova, N-doping of alumina thin film support to improve the thermal stability of catalysts: preparation and investigation, Appl. Surf. Sci.) we have developed the procedure of N-doping of alumina thin film grown at the surface of metal substrate. Proposed N-doped model alumina support is suitable for catalysis - oriented surface science studies and improves the resistance of supported metal particles against thermal driven sintering. Herein, we provide useful complementary data for the characterization of the prepared materials in the form of: in situ / ex situ XPS (X-ray photoelectron spectroscopy) spectra at every stage of sample preparation, including angle resolved XPS experiments and thermal stability tests; STM (scanning tunneling microscopy) images of supported gold catalysts. Presented data support the proposed mechanism of film formation and modification.

Electrospun Produced 3D Matrices for Covering of Vascular Stents: Paclitaxel Release Depending on Fiber Structure and Composition of the External Environment.

Paclitaxel is a natural, highly lipophilic anti proliferative drug widely used in medicine. We have studied the release of tritium-labeled paclitaxel (³H-PTX) from matrices destined for the coating of vascular stents and produced by the electrospinning method from the solutions of polycaprolactone (PCL) with paclitaxel (PTX) in hexafluoisopropanol (HFIP) and/or solutions of PCL with PTX and human serum albumin (HSA) in HFIP or HIFP-dimethyl sulphoxide (DMSO) blend. The release of PTX has been shown to depend on the composition of electrospinning solution, as well as the surrounding medium, particularly the concentration of free PTX and PTX-binding biomolecules present in human serum. It was shown that 3D matrices can completely release PTX without weight loss. Two-phase PTX release from optimized 3D matrices was obtained: ~27% of PTX was released in the first day, another 8% were released over the next 26 days. Wherein ~2.8%, ~2.3%, and ~0.25% of PTX was released on day 3, 9, and 27, respectively. Considering PTX toxicity, the rate of its diffusion through the arterial wall, and the data obtained the minimum cytostatic dose of the drug in the arterial wall will be maintained for at least three months.

Synthesis and structural characterization of Se-modified carbon-supported Ru nanoparticles for the oxygen reduction reaction.

This work is part of a continued research aimed at the understanding of the promoting role of Se in the enhancement of the electrocatalytic activity of Ru in the oxygen reduction reaction. The objective of this paper is to systematically investigate the transformation of Ru nanoparticles upon their modification with the increasing amounts of Se. The Se-modified Ru/C samples with Se:Ru ratio from 0 to 1 were prepared by reacting carbon-supported Ru nanoparticles with SeO2 followed by reductive annealing and characterized using high-resolution transmission electron microscopy, energy-dispersive X-ray, X-ray diffraction analysis, X-ray photoelectron spectroscopy, and extended X-ray absorption fine structure. The results suggest that Se strongly interacts with Ru, resulting in the chemical bond between Ru and Se and formation of Ru selenide clusters whose core at low Se content can be described as Ru2Se2O0.5. At Se:Ru = 1, high-resolution electron microscopy shows evidence of formation of core-shell particles, comprising a hexagonally packed Ru core and a Ru selenide shell with lamellar morphology. Modification of Ru nanoparticles with Se enhances their electrocatalytic activity in the oxygen reduction reaction, which is explained by the role of Se in inhibiting surface oxidation.